Musculocontractural Ehlers-Danlos syndrome and neurocristopathies: dermatan sulfate is required for Xenopus neural crest cells to migrate and adhere to fibronectin.
- Authors
- Gouignard, Nadège; Maccarana, Marco; Strate, Ina; von Stedingk, Kristoffer; Malmström, Anders; Pera, Edgar M
- Year
- 2016
- Journal
- Disease models & mechanisms
- PMID
- 27101845
- DOI
- 10.1242/dmm.024661
- PMCID
- PMC4920151
Of all live births with congenital anomalies, approximately one-third exhibit deformities of the head and face. Most craniofacial disorders are associated with defects in a migratory stem and progenitor cell population, which is designated the neural crest (NC). Musculocontractural Ehlers-Danlos syndrome (MCEDS) is a heritable connective tissue disorder with distinct craniofacial features; this syndrome comprises multiple congenital malformations that are caused by dysfunction of dermatan sulfate (DS) biosynthetic enzymes, including DS epimerase-1 (DS-epi1; also known as DSE). Studies in mice have extended our understanding of DS-epi1 in connective tissue maintenance; however, its role in fetal development is not understood. We demonstrate that DS-epi1 is important for the generation of isolated iduronic acid residues in chondroitin sulfate (CS)/DS proteoglycans in early Xenopus embryos. The knockdown of DS-epi1 does not affect the formation of early NC progenitors; however, it impairs the correct activation of transcription factors involved in the epithelial-mesenchymal transition (EMT) and reduces the extent of NC cell migration, which leads to a decrease in NC-derived craniofacial skeleton, melanocytes and dorsal fin structures. Transplantation experiments demonstrate a tissue-autonomous role for DS-epi1 in cranial NC cell migration in vivo Cranial NC explant and single-cell cultures indicate a requirement of DS-epi1 in cell adhesion, spreading and extension of polarized cell processes on fibronectin. Thus, our work indicates a functional link between DS and NC cell migration. We conclude that NC defects in the EMT and cell migration might account for the craniofacial anomalies and other congenital malformations in MCEDS, which might facilitate the diagnosis and development of therapies for this distressing condition. Moreover, the presented correlations between human DS-epi1 expression and gene sets of mesenchymal character, invasion and metastasis in neuroblastoma and malignant melanoma suggest an association between DS and NC-derived cancers.
Expression and activity of the two dermatan sulfate epimerases in Xenopus embryos. (A) Protein structures. Xenopus DS-epi1 and DS-epi2 contain cleavable signal peptides (SP, arrows), an epimerase domain and two transmembrane (TM) domains. In DS-epi1, the catalytic residues His205, Tyr261 and His450 are indicated, which are also conserved in DS-epi2. DS-epi2 contains an additional sulfotransferase-like domain. (B) RT-PCR analysis of Dse and Dsel. Histone H4 is used as the loading control. A minimum of two experiments (n≥2) was performed with three independent biological samples. (C) DS epimerase activity in early Xenopus embryos. Results are mean±s.d. from triplicates (two independent experiments). (D-E′) Whole-mount in situ hybridization of neurula embryos in the dorsal view (D,E) and in transversal section (D′,E′). The arrowheads label the pre-migratory CNC cells. The region enclosed by the dashed line demarcates the Snail2+ CNC embedded in the Dse expression domain. (F) qPCR analysis in CNC explants at stage 18. c-Myc was used as a CNC cell marker. Note that Dse but not Dsel mRNA is detected. Results are mean±s.d. from triplicates (n=4 biological replicates). (G-I′) Tailbud embryos in the lateral view (G-I) and horizontal section (G′-I′). Note that Dse and Dsel overlap with Twist expression in migrating CNC cells. Section planes are indicated with dashed straight lines. br, branchial arch segments; epi, epidermis; hy, hyoid segment; ma, mandibular segment; no, notochord.
Knockdown of DS-epi1 reduces DS epimerase activity and NC-derived structures. (A) Morpholino oligonucleotides target the translation initiation sites of Dse and Dsel. (B) Endogenous DS epimerase activity is substantially decreased by Dse-MO but only a little by Dsel-MO in stage 25 embryos. (C) Epimerase activity induced by the injection of 1 ng Dse mRNA is blocked by Dse-MO, but not by control-MO and Dsel-MO. The activity of 1 ng non-targeted Dse* mRNA is not affected by Dse-MO. Results in B and C are mean±s.d. (n=3). (D) Tadpole at stage 40 injected with control-MO. (E,F) Microinjection of Dse-MO, but not Dse-5MM-MO, induces small eyes, a lack of dorsal fin structures (arrowheads) and reduced melanocyte formation (arrow). (G,H) Transversal trunk sections of stage 38 embryos following hematoxylin and eosin staining. Note the lack of a dorsal fin (arrowhead), dorsally approaching somites and hypoplastic notochord in the Dse-morphant embryo. (I-K) Ventral view of head skeletons at stage 45 in a schematic overview (I) and following Alcian Blue staining (J,K). Injection of Dse-MO, but not control-MO, causes a reduction of NC-derived cartilage structures. br, branchial segment; hy, hyoid segment; df, dorsal fin; ma, mandibular segment; no, notochord; nt, neural tube; so, somite. The proportion of examined tadpoles or explants with the indicated phenotype was as follows: D, 70/70; E, 71/114 (microcephaly), 92/114 (reduced dorsal fin), 70/114 (less melanocytes); F, 63/63; G, 4/4; H, 4/4; J, 25/25; and K, 20/20.
Presence of IdoA in CS/DS PGs of early embryos. (A) At stage 22, IdoA is present in high molecular mass CS/DS PGs, as demonstrated by the size-fractionation of [35S]-containing PGs. The HS and CS/DS degradation products are produced by nitrous acid and Chase ABC treatment, respectively. CS/DS PGs represent 72% of the high molecular mass PGs (fractions 12-17). (B) SDS-PAGE analysis of [35S]-labeled CS/DS PGs. The same samples analyzed by gel filtration in A were separated using a 4-10% gradient SDS-PAGE following nitrous acid or, alternatively, Chase ABC or Chase B treatments. The fluography indicates CS/DS PGs (brackets) with an apparent molecular mass of 200-300 kDa (Bgn) and ∼1000 kDa (Vcan). The percentages of radioactivity in the framed areas are indicated below each lane. (C,C′) Whole-mount in situ hybridization of Bgn at stage 26. Embryo is shown in the lateral view (C) and transversally sectioned (C′). Arrowheads indicate migrating trunk neural crest cells. The section planes are indicated by the dashed straight line. (D,E) Chase B treatment degrades CS/DS chains in high molecular mass PGs in control-MO-injected embryos (D) but not Dse-MO-injected embryos (E). Bgn, biglycan; Chase, chondroitinase; Vcan, versican.
DS-epi1 regulates gene markers of the neural plate border and CNC. Whole-mount in situ hybridization of early neurula embryos in an anterior view. The injected side is marked with a star. (A-F) A single injection of Dse-MO into embryos causes expansion of Pax3 and Msx1 expression at the neural plate border (arrows). The Dse-5MM-MO has no effect. A quantification of the percentage of embryos with defects is shown in C and F. (G-T) Dse-MO has no significant effect on Sox9; however, it triggers a reduction in Foxd3 and Twist expression, as well as an expansion of c-Myc expression (arrows). Normal Twist and c-Myc expression is restored by the co-injection of Dse-MO and 250 pg Dse* mRNA. nlacZ mRNA was injected as a lineage tracer (red nuclei). A quantification of the percentage of embryos with defects is shown in I, L, P and T. The proportion of examined embryos with the indicated phenotype was as follows: A, 37/42; B, 32/38; D, 26/30; E, 30/31; G, 35/37; H, 58/63; J, 30/30; K, 26/36; M, 13/20; N, 48/61; O, 16/27; Q, 90/90; R, 77/89; and S, 15/26. ****P<0.0001 (Fisher's exact test with two-tailed P-value calculation).
DS-epi1 regulates CNC cell migration. (A-G) Anterior view of late neurula embryos. The injected side is marked with a star. Dse-MO impairs the segregation of Twist+ and Snail2+ CNC cells (arrows). The effect is reversed by 250 pg Dse* mRNA. A quantification of the percentage of embryos with defects is shown in C and G. (H-M) Lateral view of tailbud embryos. Dse-MO leads to defective migration of Twist+ CNC cells (arrow) on the injected side, which is rescued by the co-injection of 250 pg Dse* mRNA and 25 pg pcDNA3/CTAP-DSE plasmid, but not 25 pg pcDNA3/CTAP-DSE (H205A) plasmid DNA. A quantification of the percentage of embryos with defects is shown in M. (N) Western blot analysis of lysates from embryos injected with 100 pg pcDNA3/CTAP-DSE or pcDNA3/CTAP-DSE (H205A) plasmid DNA and probed for DS-epi1. α-tubulin is a loading control. br, branchial segment; ey, eye; hy, hyoid segment; ma, mandibular segment. The proportion of examined embryos with the indicated phenotype was as follows: A, 15/16; B, 30/34; D, 41/46; E, 50/65; F, 20/37; H, 25/27; I, 31/41; J, 36/44; K, 27/40; and L, 14/18. ***P<0.005; ****P<0.0001 (Fisher's exact test with two-tailed P-value calculation).
DS-epi1 has a tissue-autonomous role in CNC cell migration, adherence to fibronectin and cell polarization. (A,A′) Schemes for transplantation experiments. A CNC explant from an embryo injected with 300 pg GFP mRNA was homotypically grafted at stage 17. MOs were injected into the donor (A) or host embryo (A′). (B-E) Lateral view of embryos at stage 26. Grafted GFP+ CNC cells migrate ventrally when derived from control-MO-injected embryos (B); however, they do not properly migrate when derived from Dse-MO-injected embryos (C). br, branchial segment; hy, hyoid segment; ma, mandibular segment. The CNC cell migration was normal when the host embryo was injected with control-MO or Dse-MO (D,E). Three independent experiments were performed (n=3). (F) Scheme illustrating the culture of stage 17 morphant CNC explants on fibronectin-coated plates. (G,G′) At 2 h after plating (G), the control-MO-injected CNC explant exhibits collective cell migration in one direction (arrow). The inset shows a magnification of spread cells. After 4 h (G′), the cells migrate in distinct streams (asterisks). (H,H′) Cells of Dse-MO-injected CNC explants detach from each other and fail to adhere to the fibronectin substrate. The inset depicts a magnification of the spherical cells. (I-K) Confocal microscopy of fixed CNC cells after 5 h of explant culture on fibronectin. Phalloidin–Alexa-Fluor-488 and DAPI label F-actin and cell nuclei, respectively. The Dse-5MM-MO-injected control cell (I) exhibits lamellipodia at the leading edge (arrowhead) and stress fibers in the inner regions of the cell (arrow in inset). Dse-morphant cells (J) exhibit cortical networks of stress fibers and lack polarized protrusions. Co-injection of Dse-MO and 1 ng Dse* mRNA per embryo (K) restores the normal cytoskeleton and cell shape. (L,M) Quantification of cell spreading (L) and formation of polarized cell protrusions (M) in dissociated phalloidin-stained single cells from CNC explants following 5 h of culture on fibronectin. Cell spreading and polarized protrusions were quantified by calculating the cell size as the square number of pixels (ImageJ) and determining the percentage of cells with lamellipodia or filopodia, respectively. Uninjected and Dse-5MM-MO-injected explants exhibit a similar extent of cell spreading and formation of polarized protrusions. The reduction in the cell size and the lack of lamellipodia and filopodia are rescued by the co-injection of Dse* mRNA in Dse-morphant explants. A minimum of 100 cells per sample were evaluated in each experiment. Number of independent experiments (n≥3). Results are mean±s.d. (N) Cell–matrix adhesion of dissociated single CNC cells on fibronectin- or BSA-coated plates. Following the co-injection of MO and 300 pg GFP mRNA, CNC explants from stage 17 embryos were dissociated in Ca2+- and Mg2+-free medium and cultured for 45 min on fibronectin or BSA. The Dse-morphant cells exhibit decreased adhesion to fibronectin compared with the control and Dse-5MM-MO-injected cells. None of the analyzed cell samples exhibited significant cell adhesion to BSA. At least three independent experiments were performed for each sample (n≥3). Results are mean±s.d. The proportion of examined explants or cells with the indicated phenotype was as follows: B, 10/12; C, 11/13; D, 7/7; E, 9/9; G, 30/34; H, 26/28. Scale bars: 100 µm (G-H′); 10 µm (I-K). **P<0.01, ***P<0.001, ****P<0.0001 (one-way ANOVA multiple comparisons test with Tukey correction).
CS/DS-PGs in CNC cells. (A) qPCR analysis in uninjected CNC explants at stage 18. Note abundant expression of Itga5, Itgb1 and Sdc4. Results are mean±s.d. from triplicates (n≥4 biological replicates). (B) Dse-MO does not differentially affect the mRNA levels of Itga5, Itgb1 and Sdc4 compared with Dse-5MM-MO. Results are mean±s.d. (n≥4 biological replicates). (C) Dse-MO does not reduce the protein amount of integrin β1 in explants enriched in neural crest and epidermis of stage 18 embryos. Western blotting was performed on a 7.5% Mini-Protean TGX Stain-free gel (Bio-Rad). The loading control was ascertained prior to blotting using the ChemiDoc Touch Imaging System. Resuts is representative of two independent experiments (n=2). (D) Metabolic labeling of PGs in stage 18 CNC explants. Note that Chase B partially degrades CS/DS PGs >18 kDa. The IdoA is a rare modification because the split chains are ∼10 kDa.
| Name | Type |
|---|---|
| 35S local | drug |
| [35S]sulfate local | drug |
| 9 M urea local | drug |
| abnormal actin cytoskeleton local | phenotype |
| abnormal somite dorsal abutment local | phenotype |
| acetic acid | drug |
| Actin cytoskeleton rearrangement local | phenotype |
| agarose | drug |
| Alcian Blue local | drug |
| Ammonium acetate local | drug |
| Ammonium bicarbonate local | drug |
| AMV Reverse Transcriptase local | drug |
| anti-DS-epi1 antibody local | drug |
| anti-Flag antibody local | drug |
| anti-Intα5 antibody local | drug |
| anti-Intβ1 antibody local | drug |
| aortic smooth muscle cells local | cohort |
| apoptosis | phenotype |
| Bgn local | gene |
| bone morphogenetic proteins local | drug |
| Bone morphogenetic proteins local | drug |
| Bouin's solution local | drug |
| bovine serum albumin | drug |
| branchial arch local | phenotype |
| branchial cartilage reduction local | phenotype |
| Branchial segment local | phenotype |
| branchial stream local | phenotype |
| BSA | drug |
| Ca2+ | drug |
| CaCl2 | drug |
| Calcium acetate local | drug |
| cancer | phenotype |
| CD44 | gene |
| cell adhesion | phenotype |
| cell cycle | phenotype |
| Cell cycle progression local | phenotype |
| cell migration | phenotype |
| cell spreading local | phenotype |
| cell viability local | phenotype |
| Cell viability local | phenotype |
| Chase ABC local | drug |
| Chase B local | drug |
| Chondroitinase ABC local | drug |
| Chondroitinase B local | drug |
| Chondroitin substrate local | drug |
| Chondroitin sulfate local | drug |
| chondroitin sulfate/dermatan sulfate proteoglycans local | drug |
| CHST14 local | gene |
| cleft palate | phenotype |
| c-myc | gene |
| CNC local | cohort |
| CNC cell local | phenotype |
| CNC cell migration local | phenotype |
| CNC cells local | cohort |
| CNC cells local | phenotype |
| CNC explants local | cohort |
| CNC migration defects local | phenotype |
| CNC segment segregation local | phenotype |
| Collagen fibril assembly impairment local | phenotype |
| Complete Mini local | drug |
| congenital heart defect local | phenotype |
| Connective tissue fragility local | phenotype |
| control-MO local | drug |
| cranial neural crest local | anatomy |
| cranial neural crest local | phenotype |
| craniofacial cartilage reduction local | phenotype |
| Craniofacial features local | phenotype |
| craniofacial phenotype local | phenotype |
| Craniofacial skeleton defects local | phenotype |
| CS local | drug |
| CS/DS local | drug |
| CS/DS chains local | drug |
| CS/DS PGs local | drug |
| CS/DS proteoglycans local | drug |
| Cytokeratin local | phenotype |
| DAPI | drug |
| DE52 gel local | drug |
| decreased directionality local | phenotype |
| decreased melanocytes local | phenotype |
| Dermatan sulfate local | drug |
| Developmental abnormalities | phenotype |
| developmental stage | phenotype |
| Dialysis buffer local | drug |
| Dorsal fin defects local | phenotype |
| dorsal fin formation defect local | phenotype |
| Double-knockout mice local | cohort |
| down-slanting palpedral fissues local | phenotype |
| DS | anatomy |
| Dse local | gene |
| Dse* local | variant |
| DSE local | gene |
| Dse-5MM-MO local | drug |
| DSE-5MM-MO local | drug |
| DSE(H205A) local | variant |
| Dse-knockout mice local | cohort |
| Dsel local | gene |
| DSEL local | gene |
| Dsel.L local | gene |
| Dsel-MO local | drug |
| Dse−/− mice local | cohort |
| Dse-MO local | drug |
| DSE-MO local | drug |
| Dse-MO target sequence local | drug |
| Dse mRNA local | drug |
| Dse* mRNA local | drug |
| DSE* mRNA local | drug |
| Dse-null mice local | cohort |
| DS-epi1 local | drug |
| DS-epi1 local | gene |
| DS-epi1.L local | variant |
| DS-epi1.S local | variant |
| DS-epi2 local | gene |
| DS-epi2.L local | variant |
| DS-epi2.S local | variant |
| Dse.S local | gene |
| DTT | drug |
| early embryonic development | phenotype |
| E-cadherin | gene |
| E.coli local | drug |
| EDTA | drug |
| EEF1A1 | gene |
| eGFP | drug |
| EGTA | drug |
| embryos | cohort |
| EMT | phenotype |
| eosin | drug |
| epidermis local | phenotype |
| epidermis-enriched explants local | cohort |
| epimerase local | drug |
| Esophageal squamous cell carcinoma | phenotype |
| Eye placode local | phenotype |
| failure in cell adhesion to fibronectin local | phenotype |
| Fast SYBR Green Master Mix local | drug |
| FGF | drug |
| fibroblast growth factors local | drug |
| Fibroblast growth factors local | drug |
| fibronectin | drug |
| Flag peptide local | drug |
| formaldehyde | drug |
| Foxd3 local | gene |
| GAGs local | drug |
| GFP | drug |
| GlcA local | drug |
| glycerol | drug |
| glycine | drug |
| guanidine local | drug |
| hematoxylin | drug |
| heparan sulfate local | drug |
| Heparan sulfate local | drug |
| Heparinase I local | drug |
| Heparinase II local | drug |
| Heparinase III local | drug |
| HEPES | drug |
| high palate local | phenotype |
| HRP | drug |
| HRP-conjugated streptavidin local | drug |
| HS local | drug |
| human esophagus squamous cell carcinoma cell line local | cohort |
| hyoid arch local | phenotype |
| hyoid cartilage reduction local | phenotype |
| Hyoid segment local | phenotype |
| hyoid stream local | phenotype |
| hypoplasia of the jaw local | phenotype |
| hypoplastic notochord local | phenotype |
| IdoA local | drug |
| IdoA-containing PGs local | drug |
| Iduronic acid local | drug |
| increased cell speed local | phenotype |
| integrins local | drug |
| integrin α5β1 local | drug |
| Integrin α5β1 heterodimer local | drug |
| invasion | phenotype |
| Invasive phenotype local | phenotype |
| Itga5 local | gene |
| ITGA5 local | gene |
| ITGB1 | gene |
| KCl | drug |
| kidney function | phenotype |
| kinked shortened tail local | phenotype |
| KOH | drug |
| Laemmli Buffer local | drug |
| larger cell size local | phenotype |
| Lens placode local | phenotype |
| lyases local | drug |
| lysates local | drug |
| Malformations local | phenotype |
| malformed ears local | phenotype |
| Malignancy local | phenotype |
| Malignant melanoma local | phenotype |
| mandibular arch local | phenotype |
| mandibular cartilage reduction local | phenotype |
| Mandibular segment local | phenotype |
| mandibular stream local | phenotype |
| MBS local | drug |
| MCEDS local | phenotype |
| Melanocyte defects local | phenotype |
| melanoma local | phenotype |
| Melanoma local | phenotype |
| MEMFA local | drug |
| MES local | drug |
| Mesenchymal phenotype local | phenotype |
| mesoderm formation local | phenotype |
| metastasis | phenotype |
| Metastatic melanoma local | phenotype |
| Metastatic melanoma cohort (Bogunovic et al., 2009) local | cohort |
| Mg2+ | drug |
| MgSO4 | drug |
| midface skeletal anomaly local | phenotype |
| Miller syndrome | phenotype |
| mMessage Machine kit local | drug |
| MnCl2 local | drug |
| Modified Barth solution local | drug |
| MOPS | drug |
| morpholino oligonucleotide local | drug |
| Morpholino oligonucleotide local | drug |
| Morpholinos local | drug |
| Msx3 local | gene |
| Multisystem congenital malformations local | phenotype |
| Myc | gene |
| Nager syndrome local | phenotype |
| NaHCO3 | drug |
| NC local | cohort |
| N-ethylmaleimide local | drug |
| Neural crest local | drug |
| neural crest development local | phenotype |
| Neural crest development local | phenotype |
| neuroblastoma | phenotype |
| Neuroblastoma tumor cohort (Wang et al., 2014) local | cohort |
| neurocristopathies local | phenotype |
| Neurocristopathies local | phenotype |
| neuronal differentiation | phenotype |
| nitrous acid local | drug |
| nLacZ local | drug |
| no migration local | phenotype |
| Normal offspring local | phenotype |
| notochord local | phenotype |
| NP-40 | drug |
| Pax3 local | gene |
| pcDNA3/CTAP-DSE local | drug |
| pCR-XL-TOPO local | drug |
| pCS105 local | drug |
| pCS2 local | drug |
| PD10 columns local | drug |
| perinatal lethality | phenotype |
| pET-15b vector local | drug |
| pET-19b vector local | drug |
| PGs | drug |
| phalloidin local | drug |
| phalloidin–Alexa-Fluor-488 local | drug |
| pig brain local | anatomy |
| pleiotrophin local | drug |
| PMSF | drug |
| polarized cell protrusions local | phenotype |
| posterior development local | phenotype |
| Progressive fragility of connective tissues local | phenotype |
| propidium iodide | drug |
| protease inhibitors | drug |
| Protein A/G agarose beads local | drug |
| proteinase inhibitors local | drug |
| proteoglycan labeling local | drug |
| RAX local | gene |
| Red-Gal local | drug |
| Red-Sepharose gel local | drug |
| reduced plasma membrane protrusions local | phenotype |
| RNase A | drug |
| Sdc1 local | gene |
| Sdc3 | gene |
| Sdc4 local | gene |
| SDC4 local | gene |
| SDS-PAGE local | drug |
| skin wound healing local | phenotype |
| smaller cell size local | phenotype |
| SNAI2 local | gene |
| sodium sulfate local | drug |
| Sox2 | gene |
| Sox9 | gene |
| stage 16 embryos local | cohort |
| stage 18 CNC explants local | cohort |
| stage 26 embryos local | cohort |
| stage 28 embryos local | cohort |
| stage 38 embryos local | cohort |
| stage 40 embryos local | cohort |
| stage 45 embryos local | cohort |
| standard control MO local | drug |
| standard control-MO local | drug |
| subcutaneous infection local | phenotype |
| sulfo-NHS-LC-biotin local | drug |
| SuperScript II Reverse Transcriptase local | drug |
| Survival rate local | phenotype |
| Thermo Fisher Scientific | drug |
| Treacher Collins syndrome local | phenotype |
| Tris-buffered saline (TBS) local | drug |
| Tris-HCl | drug |
| tritium local | drug |
| Tritium local | drug |
| Triton X-100 | drug |
| Trizol | drug |
| trunk NC local | anatomy |
| Tumors local | phenotype |
| Twist | gene |
| TWIST1 | gene |
| uninjected embryos local | cohort |
| urea | drug |
| Vcan local | gene |
| ventral migration local | phenotype |
| water | drug |
| Wnts local | drug |
| Xenopus CNC cells local | cohort |
| Xenopus embryo local | cohort |
| Xenopus embryos local | cohort |
| Xenopus laevis | cohort |
| Xenopus NC model local | cohort |
| β-catenin | drug |
No uploaded files.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AlfandariD., CousinH., GaultierA., HoffstromB. G. and DeSimoneD. W. (2003). Integrin α5β1 supports the migration of Xenopus cranial neural crest on fibronectin. Dev. Biol. 260, 449-464. 10.1016/S0012-1606(03)00277-X12921745 | — | — | — |
| BaoX., MuramatsuT. and SugaharaK. (2005). Demonstration of the pleiotrophin-binding oligosaccharide sequences isolated from chondroitin sulfate/dermatan sulfate hybrid chains of embryonic pig brains. J. Biol. Chem. 280, 35318-35328. 10.1074/jbc.M50730420016120610 | — | — | — |
| BarrigaE. H., MaxwellP. H., ReyesA. E. and MayorR. (2013). The hypoxia factor Hif-1α controls neural crest chemotaxis and epithelial to mesenchymal transition. J. Cell Biol. 201, 759-776. 10.1083/jcb.20121210023712262PMC3664719 | — | — | — |
| BartoliniB., ThelinM. A., RauchU., FeinsteinR., OldbergÅ., MalmströmA. and MaccaranaM. (2012). Mouse development is not obviously affected by the absence of dermatan sulfate epimerase 2 in spite of a modified brain dermatan sulfate composition. Glycobiology 22, 1007-1016. 10.1093/glycob/cws06522496542 | — | — | — |
| BartoliniB., ThelinM. A., SvenssonL., GhiselliG., van KuppeveltT. H., MalmströmA. and MaccaranaM. (2013). Iduronic acid in chondroitin/dermatan sulfate affects directional migration of aortic smooth muscle cells. PLoS ONE 8, e66704 10.1371/journal.pone.006670423843960PMC3699603 | — | — | — |
| BogunovicD., O'NeillD. W., Belitskaya-LevyI., VacicV., YuY.-L., AdamsS., DarvishianF., BermanR., ShapiroR. and PavlickA. C. (2009). Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc. Natl. Acad. Sci. USA 106, 20429-20434. 10.1073/pnas.090513910619915147PMC2787158 | — | — | — |
| BorchersA., DavidR. and WedlichD. (2001). Xenopus cadherin-11 restrains cranial neural crest migration and influences neural crest specification. Development 128, 3049-3060.1168855510.1242/dev.128.16.3049 | — | — | — |
| BorchersA., EpperleinH.-H. and WedlichD. (2000). An assay system to study migratory behavior of cranial neural crest cells in Xenopus. Dev. Genes Evol. 210, 217-222. 10.1007/s00427005030711180825 | — | — | — |
| CasiniP., OriM., AvenosoA., D'AscolaA., TrainaP., MattinaW., PerrisR., CampoG. M., CalatroniA. and NardiI. (2008). Identification and gene expression of versican during early development of Xenopus. Int. J. Dev. Biol. 52, 993-998. 10.1387/ijdb.082582pc18956330 | — | — | — |
| CastellettiF., DonadelliR., BanterlaF., HildebrandtF., ZipfelP. F., BresinE., OttoE., SkerkaC., RenieriA. and TodeschiniM. (2008). Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc. Natl. Acad. Sci. USA 105, 2538-2543. 10.1073/pnas.070773010518268355PMC2268172 | — | — | — |
| ChangC. and Hemmati-BrivanlouA. (1998). Neural crest induction by Xwnt7B in Xenopus. Dev. Biol. 194, 129-134. 10.1006/dbio.1997.88209473337 | — | — | — |
| CheungM., ChaboissierM.-C., MynettA., HirstE., SchedlA. and BriscoeJ. (2005). The transcriptional control of trunk neural crest induction, survival, and delamination. Dev. Cell 8, 179-192. 10.1016/j.devcel.2004.12.01015691760 | — | — | — |
| DavidsonL. A., KellerR. and DeSimoneD. W. (2004). Assembly and remodeling of the fibrillar fibronectin extracellular matrix during gastrulation and neurulation in Xenopus laevis. Dev. Dyn. 231, 888-895. 10.1002/dvdy.2021715517579 | — | — | — |
| DeepaS. S., YamadaS., ZakoM., GoldbergerO. and SugaharaK. (2004). Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors: a novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J. Biol. Chem. 279, 37368-37376. 10.1074/jbc.M40303120015226297 | — | — | — |
| DeSimoneD. W., DavidsonL., MarsdenM. and AlfandariD. (2005). The Xenopus embryo as a model system for studies of cell migration. Cell Migr. 294, 235-245.10.1385/1-59259-860-9:23515576916 | — | — | — |
| FairchildC. L., ConwayJ. P., SchiffmacherA. T., TaneyhillL. A. and GammillL. S. (2014). FoxD3 regulates cranial neural crest EMT via downregulation of tetraspanin18 independent of its functions during neural crest formation. Mech. Dev. 132, 1-12. 10.1016/j.mod.2014.02.00424582980PMC4001935 | — | — | — |
| FrancoC. R. C., TrindadeE. S., RochaH. A. O., da SilveiraR. B., PaludoK. S., ChammasR., VeigaS. S., NaderH. B. and DietrichC. P. (2009). Glycosaminoglycan chains from alpha5beta1 integrin are involved in fibronectin-dependent cell migration. Biochem. Cell Biol. 87, 677-686. 10.1139/O09-04719767830 | — | — | — |
| GohK. L., YangJ. T. and HynesR. O. (1997). Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos. Development 124, 4309-4319.933427910.1242/dev.124.21.4309 | — | — | — |
| GopalS., BoberA., WhitefordJ. R., MulthauptH. A. B., YonedaA. and CouchmanJ. R. (2010). Heparan sulfate chain valency controls syndecan-4 function in cell adhesion. J. Biol. Chem. 285, 14247-14258. 10.1074/jbc.M109.05694520154082PMC2863221 | — | — | — |
| GorlinR. J., CohenM. M. and HennekamR. C. (1990). Syndromes of the Head and Neck. New York: Oxford University Press. | — | — | — |
| GustafssonR., StachteaX., MaccaranaM., GrottlingE., EklundE., MalmströmA. and OldbergÅ. (2014). Dermatan sulfate epimerase 1 deficient mice as a model for human abdominal wall defects. Birth Defects Res. Part A Clin. Mol. Terat. 100, 712-720. 10.1002/bdra.23300PMC423399125186462 | — | — | — |
| HannessonH. H., Hagner-McWhirterA., TiedemannK., LindahlU. and MalmströmA. (1996). Defructosylated Escherichia coli K4 capsular polysaccharide as a substrate for the D-glucuronyl C-5 epimerase, and an indication of a two-base reaction mechanism. Biochem. J. 313, 589-596. 10.1042/bj31305898573097PMC1216948 | — | — | — |
| HolmbornK., HabicherJ., KaszaZ., ErikssonA. S., Filipek-GorniokB., GopalS., CouchmanJ. R., AhlbergP. E., WiwegerM. and SpillmannD. (2012). On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis. J. Biol. Chem. 287, 33905-33916. 10.1074/jbc.M112.40164622869369PMC3460485 | — | — | — |
| HouS., MaccaranaM., MinT. H., StrateI. and PeraE. M. (2007). The secreted serine protease xHtrA1 stimulates long-range FGF signaling in the early Xenopus embryo. Dev. Cell 13, 226-241. 10.1016/j.devcel.2007.07.00117681134 | — | — | — |
| IozzoR. V. and SchaeferL. (2015). Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 42, 11-55. 10.1016/j.matbio.2015.02.00325701227PMC4859157 | — | — | — |
| KoshoT. (2016). CHST14/D4ST1 deficiency: a new form of Ehlers-Danlos syndrome. Pediatr. Int. 58, 88-99. 10.1111/ped.1287826646600 | — | — | — |
| Le DouarinN. M. and DupinE. (2012). The neural crest in vertebrate evolution. Curr. Opin. Genet. Dev. 22, 381-389. 10.1016/j.gde.2012.06.00122770944 | — | — | — |
| MaccaranaM., KalamajskiS., KongsgaardM., MagnussonS. P., OldbergÅ. and MalmströmA. (2009). Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin. Mol. Cell. Biol. 29, 5517-5528. 10.1128/MCB.00430-0919687302PMC2756890 | — | — | — |
| MaccaranaM., OlanderB., MalmströmJ., TiedemannK., AebersoldR., LindahlU., LiJ.-P. and MalmströmA. (2006). Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. J. Biol. Chem. 281, 11560-11568. 10.1074/jbc.M51337320016505484 | — | — | — |
| MatthewsH. K., MarchantL., Carmona-FontaineC., KuriyamaS., LarraínJ., HoltM. R., ParsonsM. and MayorR. (2008). Directional migration of neural crest cells in vivo is regulated by Syndecan-4/Rac1 and non-canonical Wnt signaling/RhoA. Development 135, 1771-1780. 10.1242/dev.01735018403410 | — | — | — |
| MayorR. and TheveneauE. (2013). The neural crest. Development 140, 2247-2251. 10.1242/dev.09175123674598 | — | — | — |
| MorenoM., MuñozR., ArocaF., LabarcaM., BrandanE. and LarraínJ. (2005). Biglycan is a new extracellular component of the Chordin–BMP4 signaling pathway. EMBO J. 24, 1397-1405. 10.1038/sj.emboj.760061515775969PMC1142540 | — | — | — |
| MuroA. F., ChauhanA. K., GajovicS., IaconcigA., PorroF., StantaG. and BaralleF. E. (2003). Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J. Cell Biol. 162, 149-160. 10.1083/jcb.20021207912847088PMC2172721 | — | — | — |
| MuñozR., MorenoM., OlivaC., OrbenesC. and LarraínJ. (2006). Syndecan-4 regulates non-canonical Wnt signalling and is essential for convergent and extension movements in Xenopus embryos. Nat. Cell Biol. 8, 492-500. 10.1038/ncb139916604063 | — | — | — |
| MüllerT., MizumotoS., SureshI., KomatsuY., VodopiutzJ., DundarM., StraubV., LingenhelA., MelmerA. and LechnerS. (2013). Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers–Danlos syndrome. Hum. Mol. Genet. 22, 3761-3772. 10.1093/hmg/ddt22723704329 | — | — | — |
| NakaoM., ShichijoS., ImaizumiT., InoueY., MatsunagaK., YamadaA., KikuchiM., TsudaN., OhtaK. and TakamoriS. (2000). Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL. J. Immun. 164, 2565-2574. 10.4049/jimmunol.164.5.256510679095 | — | — | — |
| OsadaS.-I., OhmoriS.-Y. and TairaM. (2003). XMAN1, an inner nuclear membrane protein, antagonizes BMP signaling by interacting with Smad1 in Xenopus embryos. Development 130, 1783-1794. 10.1242/dev.0040112642484 | — | — | — |
| PachecoB., MaccaranaM., GoodlettD. R., MalmströmA. and MalmströmL. (2009a). Identification of the active site of DS-epimerase 1 and requirement of N-glycosylation for enzyme function. J. Biol. Chem. 284, 1741-1747. 10.1074/jbc.M80547920019004833 | — | — | — |
| PachecoB., MalmströmA. and MaccaranaM. (2009b). Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate. J. Biol. Chem. 284, 9788-9795. 10.1074/jbc.M80933920019188366PMC2665100 | — | — | — |
| PeraE. M., AcostaH., GouignardN. and ClimentM. (2015). Whole-mount in situ hybridization and immunohistochemistry in Xenopus embryos. In Situ Hybridization Methods 99, 151-167. 10.1007/978-1-4939-2303-8_8 | — | — | — |
| PowellD. R., BlaskyA. J., BrittS. G. and ArtingerK. B. (2013). Riding the crest of the wave: parallels between the neural crest and cancer in epithelial-to-mesenchymal transition and migration. Wiley Interdiscip. Rev. Syst. Biol. Med. 5, 511-522. 10.1002/wsbm.122423576382PMC3739939 | — | — | — |
| SadaghianiB. and ThiébaudC. H. (1987). Neural crest development in the Xenopus laevis embryo, studied by interspecific transplantation and scanning electron microscopy. Dev. Biol. 124, 91-110. 10.1016/0012-1606(87)90463-53666314 | — | — | — |
| SaitoA. and MunakataH. (2007). Analysis of plasma proteins that bind to glycosaminoglycans. Biochim. Biophys. Acta 1770, 241-246. 10.1016/j.bbagen.2006.10.01517178194 | — | — | — |
| SasaiN., MizusekiK. and SasaiY. (2001). Requirement of FoxD3-class signaling for neural crest determination in Xenopus. Development 128, 2525-2536.1149356910.1242/dev.128.13.2525 | — | — | — |
| ScarpaE., SzabóA., BibonneA., TheveneauE., ParsonsM. and MayorR. (2015). Cadherin switch during EMT in neural crest cells leads to contact inhibition of locomotion via repolarization of forces. Dev. Cell 34, 421-434. 10.1016/j.devcel.2015.06.01226235046PMC4552721 | — | — | — |
| ShivelyJ. E. and ConradH. E. (1976). Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15, 3932-3942. 10.1021/bi00663a0059127 | — | — | — |
| ShworakN. W., ShirakawaM., MulliganR. C. and RosenbergR. D. (1994). Characterization of ryudocan glycosaminoglycan acceptor sites. J. Biol. Chem. 269, 21204-21214.7520439 | — | — | — |
| Simões-CostaM. and BronnerM. E. (2015). Establishing neural crest identity: a gene regulatory recipe. Development 142, 242-257. 10.1242/dev.10544525564621PMC4302844 | — | — | — |
| StachteaX. N., TykessonE., van KuppeveltT. H., FeinsteinR., MalmströmA., ReijmersR. M. and MaccaranaM. (2015). Dermatan sulfate-free mice display embryological defects and are neonatal lethal despite normal lymphoid and non-lymphoid organogenesis. PLoS ONE 10, e0140279 10.1371/journal.pone.014027926488883PMC4619018 | — | — | — |
| SubramanianA., TamayoP., MoothaV. K., MukherjeeS., EbertB. L., GilletteM. A., PaulovichA., PomeroyS. L., GolubT. R., LanderE. S.et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550. 10.1073/pnas.050658010216199517PMC1239896 | — | — | — |
| SyxD., Van DammeT., SymoensS., MaiburgM. C., van de LaarI., MortonJ., SuriM., Del CampoM., HausserI. and Hermanns-LêT. (2015). Genetic heterogeneity and clinical variability in musculocontractural Ehlers–Danlos syndrome caused by impaired Dermatan Sulfate biosynthesis. Hum. Mutat. 36, 535-547. 10.1002/humu.2277425703627 | — | — | — |
| ThelinM. A., BartoliniB., AxelssonJ., GustafssonR., TykessonE., PeraE., OldbergA., MaccaranaM. and MalmstromA. (2013). Biological functions of iduronic acid in chondroitin/dermatan sulfate. FEBS J. 280, 2431-2446. 10.1111/febs.1221423441919PMC3717172 | — | — | — |
| ThelinM. A., SvenssonK. J., ShiX., BagherM., AxelssonJ., Isinger-EkstrandA., van KuppeveltT. H., JohanssonJ., NilbertM. and ZaiaJ. (2012). Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma. Cancer Res. 72, 1943-1952. 10.1158/0008-5472.CAN-11-135122350411PMC3328612 | — | — | — |
| ThieryJ. P., AcloqueH., HuangR. Y. J. and NietoM. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890. 10.1016/j.cell.2009.11.00719945376 | — | — | — |
| TrainorP. A. and AndrewsB. T. (2013). Facial dysostoses: etiology, pathogenesis and management. Am. J. Med. Genet. C Semin. Med. Genet. 163, 283-294. 10.1002/ajmg.c.3137524123981PMC3870197 | — | — | — |
| TrowbridgeJ. M. and GalloR. L. (2002). Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 12, 117R-125R. 10.1093/glycob/cwf06612213784 | — | — | — |
| TsaiJ. H. and YangJ. (2013). Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 27, 2192-2206. 10.1101/gad.225334.11324142872PMC3814640 | — | — | — |
| TsujiT., IbaragiS. and HuG.-F. (2009). Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 69, 7135-7139. 10.1158/0008-5472.CAN-09-161819738043PMC2760965 | — | — | — |
| TuckerA. S. and SlackJ. M. W. (2004). Independent induction and formation of the dorsal and ventral fins in Xenopus laevis. Dev. Dyn. 230, 461-467. 10.1002/dvdy.2007115188431 | — | — | — |
| TuckerR. (1986). The role of glycosaminoglycans in anuran pigment cell migration. J. Embryol. Exp. Morphol. 92, 145-164.3723060 | — | — | — |
| VeigaS. S., EliasM. C. Q. B., GremskiW., PorcionattoM. A., da SilvaR., NaderH. B. and BrentaniR. R. (1997). Post-translational modifications of alpha5beta1 integrin by glycosaminoglycan chains. The alpha5beta1 integrin is a facultative proteoglycan. J. Biol. Chem. 272, 12529-12535. 10.1074/jbc.272.19.125299139704 | — | — | — |
| WangC., GongB., BushelP. R., Thierry-MiegJ., Thierry-MiegD., XuJ., FangH., HongH., ShenJ. and SuZ. (2014). The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat. Biotechnol. 32, 926-932. 10.1038/nbt.300125150839PMC4243706 | — | — | — |
| WoodsA., LongleyR. L., TumovaS. and CouchmanJ. R. (2000). Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch. Biochem. Biophys. 374, 66-72. 10.1006/abbi.1999.160710640397 | — | — | — |
| ZhangD., IghaniyanS., StathopoulosL., RolloB., LandmanK., HutsonJ. and NewgreenD. (2014). The neural crest: a versatile organ system. Birth Defects Res. C. Embryo Today 102, 275-298. 10.1002/bdrc.2108125227568 | — | — | — |
| ZhangL., MüllerT., BaenzigerJ. U. and JaneckeA. R. (2010). Congenital disorders of glycosylation with emphasis on loss of dermatan-4-sulfotransferase. Prog. Mol. Biol. Transl. Sci. 93, 289-307. 10.1016/S1877-1173(10)93012-320807649 | — | — | — |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A genome wide association study of fast beta EEG in families of European ancestry. | 2017 | 28040410 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Dermatan Sulfate: Structure, Biosynthesis, and Biological Roles. | Chen C et al. | — | 2025 | → |
| MicroRNA miR-196a controls neural crest patterning by repressing immature neural ectoderm programs in Xenopus embryos. | Godden AM et al. | — | 2025 | → |
| The <i>Xenopus</i> model as a tool for investigating craniofacial developmental disorders. | Kong Q et al. | — | 2025 | → |
| Wnt signaling pathway and retinoic acid signaling pathway involved in delamination and migration of chicken trunk NCCs and contributing to HVP phenotype. | Chen Z et al. | — | 2025 | → |
| Xenopus as a model system for studying pigmentation and pigmentary disorders. | El Mir J et al. | — | 2025 | → |
| Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration. | Pera EM et al. | — | 2024 | → |
| Histories of Dermatan Sulfate Epimerase and Dermatan 4-<i>O</i>-Sulfotransferase from Discovery of Their Enzymes and Genes to Musculocontractural Ehlers-Danlos Syndrome. | Mizumoto S et al. | — | 2023 | → |
| Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration | Pera EM et al. | — | 2023 | — |
| The Xenopus phenotype ontology: bridging model organism phenotype data to human health and development. | Fisher ME et al. | — | 2022 | → |
| A biphasic response of polymerized Type 1 collagen architectures to dermatan sulfate. | Jyothsna KM et al. | — | 2021 | → |
| Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis. | Dubail J et al. | — | 2021 | → |
| Inhibition of iduronic acid biosynthesis by ebselen reduces glycosaminoglycan accumulation in mucopolysaccharidosis type I fibroblasts. | Maccarana M et al. | — | 2021 | → |
| The structure of human dermatan sulfate epimerase 1 emphasizes the importance of C5-epimerization of glucuronic acid in higher organisms. | Hasan M et al. | — | 2021 | → |
| DSE associated musculocontractural EDS, a milder phenotype or phenotypic variability. | Schirwani S et al. | — | 2020 | → |
| Dermatan sulfate epimerase 1 and dermatan 4-<i>O</i>-sulfotransferase 1 form complexes that generate long epimerized 4-<i>O</i>-sulfated blocks. | Tykesson E et al. | — | 2018 | → |
| Gene expression of the two developmentally regulated dermatan sulfate epimerases in the Xenopus embryo. | Gouignard N et al. | — | 2018 | → |
| A genome wide association study of fast beta EEG in families of European ancestry. | Meyers JL et al. | — | 2017 | → |
| E-cigarette aerosol exposure can cause craniofacial defects in Xenopus laevis embryos and mammalian neural crest cells. | Kennedy AE et al. | — | 2017 | → |
| Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase. | Nikolovska K et al. | — | 2017 | → |
| Modeling human craniofacial disorders in <i>Xenopus</i>. | Dubey A et al. | — | 2017 | → |
| Robo signaling regulates the production of cranial neural crest cells. | Li Y et al. | — | 2017 | → |